CVS Health
CVS
91.41
+2.90
+3.28%
CVS Health
US · CVS
#168 by market cap
Listed 1970
91.41
+2.90
+3.28%
Live - 5344 symbols - heartbeat 301s ago
· 2026-11-04 08:29
Analyst consensus 17 analysts
Buy
Avg price target 114.59 +25.4%
Price target rangecurrent 91.41
Low107.00
Avg114.59
High125.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-13 | BofA Securities | -- | Buy | 110.00 |
| 2026-10-12 | Leerink Partners | -- | Buy | 112.00 |
| 2026-10-09 | TD Cowen | -- | Buy | 110.00 |
| 2026-10-07 | RBC Capital | -- | Buy | 113.00 |
| 2026-10-06 | BofA Securities | -- | Buy | 110.00 |
| 2026-10-05 | Bernstein | -- | Buy | 112.00 |
| 2026-10-02 | Evercore | -- | Buy | 125.00 |
| 2026-09-15 | Wells Fargo | -- | Buy | 123.00 |
| 2026-09-15 | BofA Securities | -- | Buy | 120.00 |
| 2026-09-09 | Wells Fargo | -- | Buy | 123.00 |
| 2026-09-09 | Bernstein | -- | Buy | 106.00 |
| 2026-09-04 | Bernstein | -- | Buy | 106.00 |
| 2026-09-03 | UBS | -- | Buy | 118.00 |
| 2026-08-31 | Jefferies | -- | Buy | 120.00 |
| 2026-08-28 | Bernstein | -- | Buy | 106.00 |
| 2026-08-26 | TD Cowen | -- | Buy | 110.00 |
| 2026-08-26 | Wells Fargo | -- | Buy | 123.00 |
| 2026-08-26 | Piper Sandler | -- | Buy | 113.00 |
| 2026-08-18 | Argus Research | -- | Buy | 114.00 |
| 2026-08-14 | Bernstein | -- | Buy | 106.00 |
| 2026-08-12 | Bernstein | -- | Buy | 106.00 |
| 2026-08-12 | J.P. Morgan | -- | Buy | 118.00 |
| 2026-08-11 | Wells Fargo | -- | Buy | 123.00 |
| 2026-08-10 | TD Cowen | -- | Buy | 110.00 |
| 2026-08-10 | Wells Fargo | -- | Buy | 123.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Bernstein moved from Hold to Buy on 2026-04-06.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-04-06 | Bernstein | Hold → Buy | 94.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | -- | ±5.60% | -5.08% (in line) |
| 2026/Q1 | 2026-05-06 | -- | ±5.84% | +7.65% (beat) |
| 2025/Q4 | 2026-02-10 | -- | ±5.46% | -0.09% (in line) |
| 2025/Q3 | 2025-10-29 | -- | ±4.86% | -1.95% (in line) |
| 2025/Q2 | 2025-07-31 | -- | ±7.83% | -0.32% (in line) |
| 2025/Q1 | 2025-05-01 | -- | ±6.20% | +4.11% (in line) |
| 2024/Q4 | 2025-02-12 | -- | ±8.33% | +14.95% (beat) |
| 2024/Q3 | 2024-11-06 | -- | ±8.11% | +11.33% (beat) |
| 2024/Q2 | 2024-08-07 | -- | ±8.21% | -3.21% (in line) |
| 2024/Q1 | 2024-05-01 | -- | ±4.84% | -16.84% (beat) |
| 2023/Q4 | 2024-02-07 | -- | ±4.75% | +3.10% (in line) |
| 2023/Q3 | 2023-11-01 | -- | ±4.93% | -0.41% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-04 08:29:54 · For reference only, not investment advice and not tailored to your situation.
CVS Health discussion 0 comments